Clinical Trials Directory

Trials / Completed

CompletedNCT05622812

Effectiveness and Safety of Restylane Lyft Lidocaine for Jawline Definition

A Randomized, Evaluator-blinded, Parallel Group, no Treatment Controlled, Multicenter Study to Evaluate Effectiveness and Safety of Restylane Lyft Lidocaine for Jawline Definition

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
140 (actual)
Sponsor
Galderma R&D · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study is designed to evaluate effectiveness and safety of Restylane Lyft Lidocaine for Jawline definition

Detailed description

A randomized, evaluator-blinded, parallel group, no treatment controlled, multicenter study to evaluate effectiveness and safety of Restylane Lyft Lidocaine for Jawline definition in Canada

Conditions

Interventions

TypeNameDescription
DEVICERestylane Lyft LidocaineTreatment for Jawline definition

Timeline

Start date
2023-02-16
Primary completion
2023-10-16
Completion
2024-06-14
First posted
2022-11-21
Last updated
2025-03-07
Results posted
2025-03-07

Locations

9 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT05622812. Inclusion in this directory is not an endorsement.

Effectiveness and Safety of Restylane Lyft Lidocaine for Jawline Definition (NCT05622812) · Clinical Trials Directory